Description What is Melanotan II? Melanotan II (MT-II) is a synthetic cyclic peptide designed to mimic alpha-melanocyte stimulating hormone (α-MSH) — a natural hormone that controls skin pigmentation. Originally developed at the University of Arizona in the 1990s, it has become one of the most studied melanocortin peptides in the world. MT-II activates multiple melanocortin receptor subtypes — particularly MC1R, MC3R, MC4R, and MC5R — which gives it a research profile that extends well beyond just tanning. What Researchers Are Exploring Skin Pigmentation & Tanning MT-II’s most studied area is melanogenesis — the process by which the skin produces melanin pigment. Research has shown it activates MC1R signalling in melanocytes, promoting melanin production and increased skin pigmentation without UV exposure. This has attracted significant interest in dermatology and photoprotection research. Sexual Function Research During early tanning research, scientists discovered MT-II had notable effects on sexual arousal and function — a finding that led directly to the development of PT-141 (Bremelanotide), which went on to achieve FDA approval. MT-II’s activation of MC3R and MC4R receptors in the brain has been explored for effects on sexual desire through central nervous system pathways. Appetite & Energy Research MT-II’s activation of MC4R has drawn interest in appetite regulation research. The melanocortin system plays a well-documented role in hunger signalling, and studies have examined MT-II’s effects on food intake and energy expenditure. Worth Noting Melanotan II has one of the longest research histories of any synthetic melanocortin peptide. It’s the parent compound from which PT-141 (Bremelanotide) was derived — a peptide that achieved full FDA approval. Its multi-receptor activity gives it a broader research profile than more selective melanocortin agonists. For research use only. Not intended for human consumption. Not approved by the FDA or TGA.
